Author

Sharad Awasthi

The University of Texas MD Anderson Cancer CenterORCID 0000-0003-2011-442XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Organism:human· 2 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1 Approach:statistical model· 1

Frequent Co-Authors

Nidhi SahniiD· 2 shared S. Stephen YiiD· 2 shared Bin FengiD· 1 shared Briana K. DenneheyiD· 1 shared C. Marcelo AldaziD· 1 shared Daniel James McGrailiD· 1 shared Farid Shahid· 1 shared Gordon Brent MillsiD· 1 shared

Activity by Year

2022-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Nidhi SahniORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Therapeutic Potential of PRMT1 as a Critical Survival Dependency Target in Multiple Myeloma

Tabish Hussain, Sharad Awasthi, Farid Shahid, S. Stephen Yi, Nidhi Sahni, C. Marcelo Aldaz

This study identifies PRMT1 as a critical survival dependency in multiple myeloma cells, showing that its inhibition reduces cell survival and impairs tumor growth.

bioRxiv · Jan 29, 2025 · PreprintCancer Biology

Beyond BRCA: Discovery of novel causes and consequences of homologous recombination deficiencies

Daniel James McGrail, Yang Li, Roger S. Smith, Bin Feng, Hui Dai, Yongsheng Li, Limei Hu, Briana K. Dennehey, Sharad Awasthi, Marc L. Mendillo, Gordon Brent Mills, Shiaw‐Yih Lin, S. Stephen Yi, Nidhi Sahni

This study identifies RNA binding proteins as novel drivers of homologous recombination deficiency in tumors, expanding the known genetic causes beyond BRCA1/2 mutations.

bioRxiv · Oct 1, 2022 · PreprintSystems Biology